Manuel Rodriguez-Justo
Overview
Explore the profile of Manuel Rodriguez-Justo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
4178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wong N, Loughrey M, Bateman A, Rodriguez-Justo M, Shepherd N
Histopathology
. 2025 Feb;
PMID: 39961619
Aims: 'Vascular intrusion' is a proposed but poorly recognised phenomenon of colorectal adenomas whereby dysplastic epithelium is forced into blood vessels. This study aimed to validate its existence and to...
2.
Rodriguez-Justo M, Mansoor W, Bird T, Eatock M, Starling N, Taniere P
BMJ Open
. 2025 Feb;
15(2):e094343.
PMID: 39915015
Objective: To develop expert consensus on the optimal testing pathway for oesophago-gastric (OG) cancer care. Methods And Analysis: The process followed a modified Delphi methodology to develop consensus on the...
3.
Al Bakir I, Curtius K, Cresswell G, Grant H, Nasreddin N, Smith K, et al.
Gut
. 2025 Jan;
PMID: 39880602
Background: The risk of developing advanced neoplasia (AN; colorectal cancer and/or high-grade dysplasia) in ulcerative colitis (UC) patients with a low-grade dysplasia (LGD) lesion is variable and difficult to predict....
4.
Acha-Sagredo A, Andrei P, Clayton K, Taggart E, Antoniotti C, Woodman C, et al.
Cancer Cell
. 2025 Jan;
43(2):292-307.e7.
PMID: 39824178
Fewer than 50% of metastatic deficient mismatch repair (dMMR) colorectal cancer (CRC) patients respond to immune checkpoint inhibition (ICI). Identifying and expanding this patient population remains a pressing clinical need....
5.
Ganguli P, Basanta C, Acha-Sagredo A, Misetic H, Armero M, Mendez A, et al.
Nat Cancer
. 2025 Jan;
6(1):158-174.
PMID: 39753721
CDKN2A is a tumor suppressor located in chromosome 9p21 and frequently lost in Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC). How CDKN2A and other 9p21 gene co-deletions affect EAC evolution...
6.
Rodriguez-Pinilla S, Garcia F, Balague O, Rodriguez-Justo M, Piris M
Haematologica
. 2024 Dec;
109(12):4150.
PMID: 39618298
In reference to our paper published in the August issue 2020 of Haematologica,1 the sentence "funded by the European Union Next Generation EU, funds that finance the actions of the...
7.
Blake N, Gaifulina R, Isabelle M, Dorney J, Rodriguez-Justo M, Lau K, et al.
BJC Rep
. 2024 Nov;
2(1):52.
PMID: 39516661
Background: The clinical potential of Raman spectroscopy is well established but has yet to become established in routine oncology workflows. One barrier slowing clinical adoption is a lack of evidence...
8.
Short E, Adcock I, Al-Sarireh B, Ager A, Ajjan R, Akbar N, et al.
medRxiv
. 2024 Sep;
PMID: 39281746
Background: Around the world, individuals are living longer, but an increased average lifespan does not always equate to an increased healthspan. With advancing age, the increased prevalence of ageing-related diseases...
9.
Deng J, Pan T, Wang D, Hong Y, Liu Z, Zhou X, et al.
EMBO Mol Med
. 2024 Aug;
16(9):2080-2108.
PMID: 39103698
Chemotherapy, the standard of care treatment for cancer patients with advanced disease, has been increasingly recognized to activate host immune responses to produce durable outcomes. Here, in colorectal adenocarcinoma (CRC)...
10.
Al Bakir I, Curtius K, Cresswell G, Grant H, Nasreddin N, Smith K, et al.
medRxiv
. 2024 Jul;
PMID: 39040198
Patients with inflammatory bowel disease (IBD) are at increased risk of colorectal cancer (CRC), and this risk increases dramatically in those who develop low-grade dysplasia (LGD). However, there is currently...